The Gross Margin of Y-mAbs Therapeutics Inc (YMAB) is 82.89%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 82.89% |
| 2023-12-31 | 86.60% |
| 2022-12-31 | 88.56% |
| 2021-12-31 | 93.41% |